A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site
Ty A. Sornberger(Bipar), Seth J. Zost(Vanderbilt University Medical Center), Laura S. Handal, Rachel E. Sutton(Vanderbilt University Medical Center), Elaine C Chen(Bipar), Pavlo Gilchuk(AstraZeneca (Japan)), Lauren E. Williamson(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Elad Binshtein, Ryan P. Irving(Vanderbilt University Medical Center), Rachael M. Wolters(Vanderbilt University Medical Center), Andrew Trivette, Katherine Webb(Vanderbilt University), Chandrahaas R. Kona(Vanderbilt University Medical Center), Iuliia M. Gilchuk(Vanderbilt University Medical Center), Eduardo Sanz de Villalobos(Vanderbilt University Medical Center), Luke Myers(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Mxra8 is a receptor for multiple arthritogenic alphaviruses
|Nature|2018|455